“Rising Use of Chlorine in Pharmaceutical Intermediates”
- The pharmaceutical sector is increasingly relying on chlorine-based intermediates for synthesizing antibiotics, antiseptics, and various active pharmaceutical ingredients (APIs).
- Chlorine’s reactivity and ability to form stable compounds make it ideal for producing high-purity chemicals required in drug manufacturing.
- The push for localized API production and pandemic-driven investments in healthcare infrastructure is boosting chlorine demand.
- For instance, in August 2023, BASF expanded its chlorine-based chemical production facilities in Germany to cater to rising pharmaceutical-grade intermediate demand.
- As global health concerns persist and pharma production scales up, chlorine usage in pharmaceutical synthesis is expected to grow steadily, particularly in Europe and Asia-Pacific
